Reports for TENOFOVIR DISOPROXIL FUMARATE

Ingredient

TENOFOVIR DISOPROXIL FUMARATE

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
MYLAN-EMTRICITABINE/TENOFOVIR DISOPROXIL 300MG 200MG TABLET Resolved 2019-07-29 2019-09-26 90113
MYLAN-EMTRICITABINE/TENOFOVIR DISOPROXIL 300MG 200MG TABLET Avoided shortage 2020-05-06 2020-05-12 114152
MYLAN-EMTRICITABINE/TENOFOVIR DISOPROXIL 200MG 300MG TABLET Resolved 2022-01-26 2022-02-04 153490
MYLAN-EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE 600MG 300MG 200MG TABLET Resolved 2018-04-27 2019-06-19 47356
MYLAN-EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE 600MG 300MG 200MG TABLET Resolved 2019-06-25 2019-07-03 87463
MYLAN-EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE 600MG 200MG 300MG TABLET Avoided shortage 2020-04-29 2020-07-09 113424
APO-TENOFOVIR 300MG TABLET Resolved 2018-07-25 2018-09-04 56538
APO-TENOFOVIR 300MG TABLET Resolved 2020-09-30 2020-11-16 125338
APO-EMTRICITABINE-TENOFOVIR 300MG 200MG TABLET Resolved 2017-09-27 2017-10-02 23663
APO-EMTRICITABINE-TENOFOVIR 300MG 200MG TABLET Resolved 2018-03-05 2018-03-20 41868

Showing 11 to 20 of 41

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
ATRIPLA 300MG 200MG 600MG TABLET Discontinued 2021-08-17 2022-01-01 144260

Showing 1 to 1 of 1